Monitoring of antigen-specific CD8 T cells in patients with type 1 diabetes treated with antiCD3 monoclonal antibodies

Clinical Immunology

Volumn 134, Issue 2, 2010, Pages 121-129

  Cernea, Simona ^a   Herold, Kevan C ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AntiCD3 monoclonal antibody; CD8 T cells; Tetramer; Type 1 diabetes

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; GLUTAMATE DECARBOXYLASE 65; HLA A2 ANTIGEN; IGRP PROTEIN; INSULIN A 1 PROTEIN; INSULIN A 2 PROTEIN; INSULIN B PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCLONAL ANTIBODY CD3; PREPROINSULIN; PROTEIN; TEPLIZUMAB; TETRAMER; UNCLASSIFIED DRUG;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; BLOOD DONOR; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG DOSE INCREASE; EFFECTOR CELL; FROZEN SECTION; GENE FREQUENCY; HUMAN; HUMAN CELL; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MEMORY CELL; PATHOGENICITY; PATIENT MONITORING; PHENOTYPE; PRIORITY JOURNAL; STAINING;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; CD8-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; DIABETES MELLITUS, TYPE 1; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MUROMONAB-CD3; OLIGOPEPTIDES; PHENOTYPE;

EID: 73349105249     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2009.09.005     Document Type: Article

References (43)

1. Atkinson M.A., and ADA Outstanding Scientific Achievement Lecture. Thirty years of investigating the autoimmune basis for type 1 diabetes: why can't we prevent or reverse this disease?. Diabetes 54 2005 (2004) 1253-1263
2. Miller B.J., Appel M.C., O'Neil J.J., and Wicker L.S. Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J. Immunol. 140 (1988) 52-58
3. Christianson S.W., Shultz L.D., and Leiter E.H. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Diabetes 42 (1993) 44-55
4. Katz J.D., Wang B., Haskins K., Benoist C., and Mathis D. Following a diabetogenic T cell from genesis through pathogenesis. Cell 74 (1993) 1089-1100
5. Amrani A., Verdaguer J., Serra P., Tafuro S., Tan R., and Santamaria P. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Nature 406 (2000) 739-742
6. Qin H., Trudeau J.D., Reid G.S., Lee I.F., Dutz J.P., Santamaria P., Verchere C.B., and Tan R. Progression of spontaneous autoimmune diabetes is associated with a switch in the killing mechanism used by autoreactive CTL. Int. Immunol. 16 (2004) 1657-1662
7. Santamaria P. Kinetic evolution of a diabetogenic CD8+ T cell response. Ann. N. Y. Acad. Sci. 1005 (2003) 88-97
8. Itoh N., Hanafusa T., Miyazaki A., Miyagawa J., Yamagata K., Yamamoto K., Waguri M., Imagawa A., Tamura S., Inada M., et al. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J. Clin. Invest. 92 (1993) 2313-2322
9. Dotta F., Censini S., van Halteren A.G., Marselli L., Masini M., Dionisi S., Mosca F., Boggi U., Muda A.O., Prato S.D., Elliott J.F., Covacci A., Rappuoli R., Roep B.O., and Marchetti P. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 5115-5120
10. Reijonen H., and Kwok W.W. Use of HLA class II tetramers in tracking antigen-specific T cells and mapping T-cell epitopes. Methods 29 (2003) 282-288
11. Nepom G.T., Buckner J.H., Novak E.J., Reichstetter S., Reijonen H., Gebe J., Wang R., Swanson E., and Kwok W.W. HLA class II tetramers: tools for direct analysis of antigen-specific CD4+ T cells. Arthritis Rheum. 46 (2002) 5-12
12. Seyfert-Margolis V., Gisler T.D., Asare A.L., Wang R.S., Dosch H.M., Brooks-Worrell B., Eisenbarth G.S., Palmer J.P., Greenbaum C.J., Gitelman S.E., Nepom G.T., Bluestone J.A., and Herold K.C. Analysis of T-cell assays to measure autoimmune responses in subjects with type 1 diabetes: results of a blinded controlled study. Diabetes 55 (2006) 2588-2594
13. Martinuzzi E., Lemonnier F.A., Boitard C., and Mallone R. Measurement of CD8 T cell responses in human type 1 diabetes. Ann. N. Y. Acad. Sci. 1150 (2008) 61-67
14. Martinuzzi E., Novelli G., Scotto M., Blancou P., Bach J.M., Chaillous L., Bruno G., Chatenoud L., van Endert P., and Mallone R. The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment. Diabetes 57 (2008) 1312-1320
15. Pinkse G.G., Tysma O.H., Bergen C.A., Kester M.G., Ossendorp F., van Veelen P.A., Keymeulen B., Pipeleers D., Drijfhout J.W., and Roep B.O. Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 18425-18430
16. Herold K.C., Gitelman S.E., Masharani U., Hagopian W., Bisikirska B., Donaldson D., Rother K., Diamond B., Harlan D.M., and Bluestone J.A. A single course of anti-CD3 monoclonal antibody hOKT3{gamma}1(Ala-Ala) results in improvement in c-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes. Diabetes 54 (2005) 1763-1769
17. Herold K.C., Hagopian W., Auger J.A., Poumian-Ruiz E., Taylor L., Donaldson D., Gitelman S.E., Harlan D.M., Xu D., Zivin R.A., and Bluestone J.A. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N. Engl. J. Med. 346 (2002) 1692-1698
18. Keymeulen B., Vandemeulebroucke E., Ziegler A.G., Mathieu C., Kaufman L., Hale G., Gorus F., Goldman M., Walter M., Candon S., Schandene L., Crenier L., De Block C., Seigneurin J.M., De Pauw P., Pierard D., Weets I., Rebello P., Bird P., Berrie E., Frewin M., Waldmann H., Bach J.F., Pipeleers D., and Chatenoud L. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N. Engl. J. Med. 352 (2005) 2598-2608
19. Herold K.C., Bluestone J.A., Montag A.G., Parihar A., Wiegner A., Gress R.E., and Hirsch R. Prevention of autoimmune diabetes with nonactivating anti-CD3 monoclonal antibody. Diabetes 41 (1992) 385-391
20. Hirsch R., Bluestone J.A., DeNenno L., and Gress R.E. Anti-CD3 F(ab')2 fragments are immunosuppressive in vivo without evoking either the strong humoral response or morbidity associated with whole mAb. Transplantation 49 (1990) 1117-1123
21. Hirsch R., Eckhaus M., Auchincloss H., Sachs D.H., and Bluestone J.A. Effects of in vivo administration of anti-T3 monoclonal antibody on T cell function in mice. I. Immunosuppression of transplantation responses. J. Immunol. 140 (1988) 3766-3772
22. Woodle E.S., Bluestone J.A., Zivin R.A., Jolliffe L.K., Auger J., Xu D., and Thistlethwaite J.R. Humanized, nonmitogenic OKT3 antibody, huOKT3 gamma(Ala-Ala): initial clinical experience. Transplant. Proc. 30 (1998) 1369-1370
23. Xu D., Alegre M.L., Varga S.S., Rothermel A.L., Collins A.M., Pulito V.L., Hanna L.S., Dolan K.P., Parren P.W., Bluestone J.A., Jolliffe L.K., and Zivin R.A. In vitro characterization of five humanized OKT3 effector function variant antibodies. Cell. Immunol. 200 (2000) 16-26
24. Hong M.S., Dan J.M., Choi J.Y., and Kang I. Age-associated changes in the frequency of naive, memory and effector CD8+ T cells. Mech. Ageing Dev. 125 (2004) 615-618
25. Sallusto F., Lenig D., Forster R., Lipp M., and Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401 (1999) 708-712
26. Ravkov E.V., Myrick C.M., and Altman J.D. Immediate early effector functions of virus-specific CD8+CCR7+ memory cells in humans defined by HLA and CC chemokine ligand 19 tetramers. J. Immunol. 170 (2003) 2461-2468
27. Verge C.F., Gianani R., Kawasaki E., Yu L., Pietropaolo M., Jackson R.A., Chase H.P., and Eisenbarth G.S. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45 (1996) 926-933
28. Wenzlau J.M., Juhl K., Yu L., Moua O., Sarkar S.A., Gottlieb P., Rewers M., Eisenbarth G.S., Jensen J., Davidson H.W., and Hutton J.C. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 17040-17045
29. Carpenter P.A., Appelbaum F.R., Corey L., Deeg H.J., Doney K., Gooley T., Krueger J., Martin P., Pavlovic S., Sanders J., Slattery J., Levitt D., Storb R., Woolfrey A., and Anasetti C. A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease. Blood 99 (2002) 2712-2719
30. Kang I., Quan T., Nolasco H., Park S.H., Hong M.S., Crouch J., Pamer E.G., Howe J.G., and Craft J. Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus. J. Immunol. 172 (2004) 1287-1294
31. Hedman M., Faresjo M., Axelsson S., Ludvigsson J., and Casas R. Impaired CD4 and CD8 T cell phenotype and reduced chemokine secretion in recent-onset type 1 diabetic children. Clin. Exp. Immunol. 153 (2008) 360-368
32. Monti P., Scirpoli M., Rigamonti A., Mayr A., Jaeger A., Bonfanti R., Chiumello G., Ziegler A.G., and Bonifacio E. Evidence for in vivo primed and expanded autoreactive T cells as a specific feature of patients with type 1 diabetes. J. Immunol. 179 (2007) 5785-5792
33. Miller J.D., van der Most R.G., Akondy R.S., Glidewell J.T., Albott S., Masopust D., Murali-Krishna K., Mahar P.L., Edupuganti S., Lalor S., Germon S., Del Rio C., Mulligan M.J., Staprans S.I., Altman J.D., Feinberg M.B., and Ahmed R. Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity 28 (2008) 710-722
34. Betts M.R., Price D.A., Brenchley J.M., Lore K., Guenaga F.J., Smed-Sorensen A., Ambrozak D.R., Migueles S.A., Connors M., Roederer M., Douek D.C., and Koup R.A. The functional profile of primary human antiviral CD8+ T cell effector activity is dictated by cognate peptide concentration. J. Immunol. 172 (2004) 6407-6417
35. Herold K.C., Burton J.B., Francois F., Poumian-Ruiz E., Glandt M., and Bluestone J.A. Activation of human T cells by FcR nonbinding anti-CD3 mAb, hOKT3gamma1(Ala-Ala). J. Clin. Invest. 111 (2003) 409-418
36. Bisikirska B., Colgan J., Luban J., Bluestone J.A., and Herold K.C. TCR stimulation with modified anti-CD3 mAb expands CD8 T cell population and induces CD8CD25 Tregs. J. Clin. Invest. 115 (2005) 2904-2913
37. Herold K.C., Gitelman S., Greenbaum C., Puck J., Hagopian W., Gottlieb P., Sayre P., Bianchine P., Wong E., Seyfert-Margolis V., Bourcier K., and Bluestone J.A. Treatment of patients with new onset type 1 diabetes with a single course of anti-CD3 mAb Teplizumab preserves insulin production for up to 5 years. Clin. Immunol. 132 (2009) 166-173
38. Takahashi K., Honeyman M.C., and Harrison L.C. Cytotoxic T cells to an epitope in the islet autoantigen IA-2 are not disease-specific. Clin. Immunol. 99 (2001) 360-364
39. Hassainya Y., Garcia-Pons F., Kratzer R., Lindo V., Greer F., Lemonnier F.A., Niedermann G., and van Endert P.M. Identification of naturally processed HLA-A2-restricted proinsulin epitopes by reverse immunology. Diabetes 54 (2005) 2053-2059
40. van Endert P., Hassainya Y., Lindo V., Bach J.M., Blancou P., Lemonnier F., and Mallone R. HLA class I epitope discovery in type 1 diabetes. Ann. N. Y. Acad. Sci. 1079 (2006) 190-197
41. Mallone R., Martinuzzi E., Blancou P., Novelli G., Afonso G., Dolz M., Bruno G., Chaillous L., Chatenoud L., Bach J.M., and van Endert P. CD8+ T-cell responses identify beta-cell autoimmunity in human type 1 diabetes. Diabetes 56 (2007) 613-621
42. Panina-Bordignon P., Lang R., van Endert P.M., Benazzi E., Felix A.M., Pastore R.M., Spinas G.A., and Sinigaglia F. Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes. J. Exp. Med. 181 (1995) 1923-1927
43. Takaki T., Marron M.P., Mathews C.E., Guttmann S.T., Bottino R., Trucco M., DiLorenzo T.P., and Serreze D.V. HLA-A*0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes. J. Immunol. 176 (2006) 3257-3265